CD276 and colorectal carcinoma: Secondly, our study might be overestimated; as there are two retrospective cohort studies included which might have higher risk of biases.18,20 Hence, larger and well-designed randomized controlled trial are needed to further assess the relationship between the B7-H3 over expression and CRC prognosis.